Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial

Autor: LOCATELLI F, NOLLKE P, ZECCA M, KORTHOF E, LANINO E, PETERS C, KABISCH H, UDERZO C, BONFIM CS, BADER P, DILLOO D, STARY J, FISCHER A, REVESZ T, FUHRER M, HASLE H, TREBO M, VAN DEN HEUVEL EIBRINK MM, FENU S, STRAHM B, GIORGIANI G, BONORA MR, DUFFNER U, NIEMEYER CM, EUROPEAN WORKING GROUP ON CHILDHOOD MDS, EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP, PESSION, ANDREA

Publikováno v: Locatelli, F, Nöllke, P, Zecca, M, Korthof, E, Lanino, E, Peters, C, Pession, A, Kabisch, H, Uderzo, C, Bonfim, CS, Bader, P, Dilloo, D, Stary, J, Fischer, A, Revesz, T, Führer, M, Hasle, H, Trebo, M, Heuvel-Eibrink, MM, Fenu, S, Strahm, B, Giorgiani, G, Bonora, MR, Duffner, U & Niemeyer, CM 2005, ' Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial ', Blood, vol. 105, pp. 410-419 .
Blood, 105(1), 410-419. American Society of Hematology

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only proven curative therapy for juvenile myelomonocytic leukemia (JMML). We, the European Working Group on Childhood MDS (EWOG-MDS) and the European Blood and Marrow Transplantation (E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505f7b5b301d88c559e49421637f3653
https://doi.org/10.1182/blood-2004-05-1944

Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States

Autor: Kwan, A, Abraham, RS, Currier, R, Brower, A, Andruszewski, K, Abbott, JK, Baker, M, Ballow, M, Bartoshesky, LE, Bonilla, FA, Brokopp, C, Brooks, E, Caggana, M, Celestin, J, Church, JA, Comeau, AM, Connelly, JA, Cowan, MJ, Cunningham-Rundles, C, Dasu, T, Dave, N, De La Morena, MT, Duffner, U, Fong, CT, Forbes, L, Freedenberg, D, Gelfand, EW, Hale, JE, Hanson, IC, Hay, BN, Hu, D, Infante, A, Johnson, D, Kapoor, N, Kay, DM, Kohn, DB, Lee, R, Lehman, H, Lin, Z, Lorey, F, Abdel-Mageed, A, Manning, A, McGhee, S, Moore, TB, Naides, SJ, Notarangelo, LD, Orange, JS, Pai, SY, Porteus, M, Rodriguez, R, Romberg, N, Routes, J, Ruehle, M, Rubenstein, A, Saavedra-Matiz, CA, Scott, G, Scott, PM, Secord, E, Seroogy, C, Shearer, WT, Siegel, S, Silvers, SK, Stiehm, ER, Sugerman, RW, Sullivan, JL, Tanksley, S, Tierce, ML, Verbsky, J, Vogel, B, Walker, R, Walkovich, K, Walter, JE, Wasserman, RL, Watson, MS, Weinberg, GA, Weiner, LB, Wood, H, Yates, AB, Puck, JM

Publikováno v: Kwan, A; Abraham, RS; Currier, R; Brower, A; Andruszewski, K; Abbott, JK; et al.(2014). Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA-Journal of the American Medical Association, 312(7), 729-738. doi: 10.1001/jama.2014.9132. UCSF: Retrieved from: http://www.escholarship.org/uc/item/2qh1q6qx

Importance: Newborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended uniform panel for newborn screened di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::053891f8f39178fe506459192e3a44b3
http://www.escholarship.org/uc/item/2qh1q6qx

Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia [4]

Autor: Yoshimi, A., Mohamed, M., Bierings, M., Urban, C., Korthof, E., Zecca, M., Sykora, K. -W., Duffner, U., Trebo, M., Matthes-Martin, S., Sedlacek, P., Klingebiel, T., Lang, P., Fuhrer, M., Claviez, A., Wossmann, W., Pession, A., Arvidson, J., O'Marcaigh, A. S., van den Heuvel-Eibrink, M. M., Stary, J., Hasle, H., Nollke, P., Locatelli, F., Niemeyer, C. M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::9b93ec7a14409178bee81b86f1a4c0dd
http://hdl.handle.net/11573/1489423

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.